Abstract
Psychotic symptoms in subjects with Alzheimer disease (AD with psychosis, AD+P) define a phenotype characterized by greater cognitive burden than in AD without psychosis. We have proposed that genes of small effect may contribute to the risk for expression of psychosis in multiple disorders, including AD. Recently, sex-differential association of a three-locus haplotype, including a G → A transition at codon 108/158 of catechol-O-methyltransferase (COMT) resulting in a Val → Met substitution, has been reported to confer an increased risk for schizophrenia. The main objective of the study was to determine if COMT genetic variation is associated with risk of psychosis in AD, and included a case–control study of 373 individuals diagnosed with AD with, or without, psychosis. All subjects were characterized for alleles at the three loci associated with schizophrenia, RS737865, COMT G → A 108/158 (RS4680), and RS165599, and for a C/T transition adjacent to an estrogen response element (ERE6) in the COMT P2 promoter region. Both single locus and haplotype tests of association were conducted. Logit models were used to examine independent and interacting effects of alleles at the associated loci. All analyses were stratified by sex. In female subjects, RS4680 demonstrated a modest association with AD+P; RS737865 demonstrated a trend towards an association. There was a highly significant association of AD+P with the four-locus haplotype, which resulted from additive effects of alleles at RS4680 and ERE6 (or RS737865, as this locus was in almost absolute linkage disequilibrium (LD) with ERE6). In male subjects, no single locus test was significant, but there remained a strong association between AD+P and the four-locus haplotype. This association appeared to result from interaction of the ERE6/RS737865, RS4680, and RS165599 loci. Genetic variation in COMT is associated with AD+P, and thus appears to contribute to psychosis risk across disorders. Sex-differential associations of COMT with psychosis may result from variation at, or in LD with, ERE6. Examination of variation at ERE6 in subjects with schizophrenia, and further examination of the independent and additive effects of variations in COMT on gene expression, is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sweet RA, Nimgaonkar VL, Devlin B, Jeste DV . Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 2003; 8: 383–392.
Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST . Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002; 58: 907–911.
Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA . Heritability of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 2005; 13: (in press).
Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA . Linkage analysis of Alzheimer disease with psychosis. Neurology 2002; 59: 118–120.
Go RC, Perry RT, Weiner H, Bassett SS, Blacker D, Devlin BJ et al. Neuregulin-1 polymorphism in LOAD with psychosis in the NIMH AD sibling families. Neurobiol Aging 2004; 25: 488.
Sweet RA, Nimgaonkar VL, Kamboh MI, Lopez OL, Zhang F, DeKosky ST . Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. Arch Neurol 1998; 55: 1335–1340.
Holmes C, Arranz MJ, Powell JF, Collier D, Lovestone S . 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet 1998; 7: 1507–1509.
Sweet RA, Pollock BG, Sukonick DL, Mulsant BH, Rosen J, Klunk WE et al. The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer's disease. Int Psychogeriatr 2001; 13: 401–409.
Sweet RA, Panchalingam K, Pettegrew JW, McClure RJ, Hamilton RL, Lopez OL et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 2002; 23: 547–553.
Drevets WC, Rubin EH . Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 1989; 25: 39–48.
Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST . Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 1999; 56: 1266–1272.
Levy ML, Cummings J, Fairbanks LA, Bravi D, Calvani M, Carta A . Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996; 153: 1438–1443.
Ballard CG, O'Brien JT, Coope B, Wilcock G . Psychotic symptoms in dementia and the rate of cognitive decline. J Am Geriatr Soc 1997; 45: 1031–1032.
Paulsen JS, Salmon DP, Thal L, Romero R, Weisstein-Jenkins C, Galasko D et al. Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neurology 2000; 54: 1965–1971.
Grossman MH, Emanuel BS, Budarf ML . Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 1992; 12: 822–825.
Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 1997; 61: 620–629.
Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996; 67: 468–472.
Murphy KC, Jones LA, Owen MJ . High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940–945.
Axelrod J, Tomchick R . Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958; 233: 702–705.
Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM . Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243–250.
Glatt SJ, Faraone SV, Tsuang MT . Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case–control and family-based studies. Am J Psychiatry 2003; 160: 469–476.
Shifman S, Bronstein MSM, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296–1302.
Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R, Bambara RA . Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 1998; 273: 29321–29330.
Xie T, Ho SL, Ramsden D . Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999; 56: 31–38.
Lopez OL, Becker JT, Klunk WE, Saxton J, Hamilton RL, Kaufer DI et al. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades. I. Neurology 2000; 55: 1854–1862.
Lopez OL, Becker JT, Klunk WE, Saxton J, Hamilton RL, Kaufer D et al. Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades. II. Neurology 2000; 55: 1863–1869.
Mulsant BH, Mazumdar S, Pollock BG, Sweet RA, Rosen J, Lo K . Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1996; 12: 537–547.
Cook SE, Miyahara S, Bacanu SA, Perez-Madrinan G, Lopez OL, Kaufer DI et al. Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am J Geriatr Psychiatry 2003; 11: 406–413.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939–944.
Auer SR, Monteiro IM, Reisberg B . The empirical behavioral pathology in Alzheimer's disease (E-BEHAVE-AD) rating scale. Int Psychogeriatr 1996; 8: 247–266.
Tariot PN, Mack JL, Patterson MB, Edland SD, Weiner MF, Fillenbaum G, et al., Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152: 1349–1357.
Perez-Madrinan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI et al. Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. Am J Geriatr Psychiatry 2004; 12: 449–456.
Kinnear C, Niehaus DJ, Seedat S, Moolman-Smook JC, Corfield VA, Mahherke G et al. Obsessive–compulsive disorder and a novel polymorphism adjacent to the oestrogen response element (ERE6) upstream from the COMT gene. Psychiatr Genet 2001; 11: 85–87.
Chen X, Levine L, Kwok PY . Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 1999; 9: 492–498.
Seltman H, Roeder K, Devlin B . Evolutionary-based association analysis using haplotype data. Genet Epidemiol 2003; 25: 48–58.
Templeton AR, Boerwinkle E, Sing CF . A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 1987; 117: 343–351.
Templeton AR, Sing CF, Kessling A, Humphries S . A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics 1988; 120: 1145–1154.
Templeton AR, Crandall KA, Sing CF . A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 1992; 132: 619–633.
Templeton AR, Sing CF . A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram uncertainty and recombination. Genetics 1993; 134: 659–669.
Haviland MB, Ferrell RE, Sing CF . Association between common alleles of the low-density lipoprotein receptor gene region and interindividual variation in plasma lipid and apolipoprotein levels in a population-based sample from Rochester, Minnesota. Hum Genet 1997; 99: 108–114.
Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998; 7: 1745–1751.
Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, Matsuda F et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 2002; 10: 553–561.
Tzeng JY . Evolutionary-based grouping of haplotypes in association analysis. Genet Epidemiol 2005; 28: 220–231.
Crandall KA, Templeton AR . Empirical tests of some predictions from coalescent theory with applications to intraspecific phylogeny reconstruction. Genetics 1993; 134: 959–969.
Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 1999; 8: 237–245.
Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12: 23–32.
Pericak-Vance MA, Gaskell PC, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997; 278: 1237–1241.
Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L et al. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000; 35: 1343–1352.
Borroni B, Agosti C, Archetti S, Costanzi C, Bonomi S, Ghianda D et al. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease. Neurosci Lett 2004; 370: 127–129.
Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73: 152–161.
Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry 2004; 10: 589–597.
Chen JS, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al. Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807–821.
Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen JS, Hyde TM et al. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003; 28: 1521–1530.
Tunbridge E, Burnet PWJ, Sodhi MS, Harrison PJ . Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 2004; 51: 112–118.
Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS . Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 2004; 9: 962–967.
DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A et al. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 2002; 111: 521–537.
Worda C, Sator MO, Schneeberger CS, Jantschev T, Ferlitsch K, Huber JC . Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 2003; 18: 262–266.
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917–6922.
Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002; 52: 701–707.
Jeste DV, Finkel SI . Psychosis of Alzheimer's disease and related dementias. Am J Geriatr Psychiatry 2000; 8: 29–34.
Stern Y, Mayeux R, Sano M, Hauser WA, Bush T . Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987; 37: 1649–1653.
Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ . Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992; 149: 184–189.
Rockwell E, Jackson E, Vilke G, Jeste DV . A study of delusions in a large cohort of Alzheimer's disease patients. Am J Geriatr Psychiatry 1994; 2: 157–164.
Lopez OL, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST . The apolipoprotein E ɛ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49: 794–797.
Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF . Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991; 41: 906–912.
Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B-Neuropsychiatr Genet 2004; 128B: 61–64.
Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.
Stephens M, Donnelly P . A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–1169.
Devlin B, Risch N . A Comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311–322.
Acknowledgements
This study is supported in part by Research Grants AG05133, AG16976, MH71533, MH66231, MH57881, MH59666, MH65416, MH64173, MH52247, MH30915, and RR00056 from the National Institutes of Health. SAB is the recipient of a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression. We gratefully acknowledge the efforts of the research staff of the Alzheimer Disease Research Center and the Geriatric Psychopharmacology Program at the University of Pittsburgh.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sweet, R., Devlin, B., Pollock, B. et al. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol Psychiatry 10, 1026–1036 (2005). https://doi.org/10.1038/sj.mp.4001709
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001709
Keywords
This article is cited by
-
Catechol-O-Methyltransferase Val158Met Polymorphism on Striatum Structural Covariance Networks in Alzheimer’s Disease
Molecular Neurobiology (2018)
-
Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence
Psychopharmacology (2013)
-
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
BMC Neuroscience (2009)
-
Catechol-O-Methyltransferase (COMT): A Gene Contributing to Sex Differences in Brain Function, and to Sexual Dimorphism in the Predisposition to Psychiatric Disorders
Neuropsychopharmacology (2008)
-
Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer’s Disease
NeuroMolecular Medicine (2008)